United Effort Towards an HIV Cure

CRISPR for Cure is 1 of 10 Martin Delaney Collaboratories for HIV Cure in the country. We use cutting edge technology in basic and translational HIV cure research.

Learn about our program

Searching for a cure for the 38 million people living with HIV

It has been over 40 years since the first reported case of HIV and today we are closer to a cure than ever.

Our goal is to implement a genetic strategy using CRISPR gene editing platform for the permanent inactivation of HIV and enhancement of the immune system.

Collaborating for success

It takes a village to find an HIV cure. CRISPR for Cure is a highly collaborative and synergistic research program with academic, industry, government, and community partnerships.


October 18 at 12:00 pm ET: Gene Therapy in Germany Webinar presented by Dr. Joachim Hauber of PROVIREX Genome Editing Therapies

Register now

What’s Happening

Science Magazine | 09/21/2022
First individual treated with CRISPR-based HIV therapy, a breakthrough treatment pioneered by researchers at Lewis Katz School of Medicine at Temple University and developed by Excision BioTherapeutics
Read more Read more link
Excision BioTherapeutics | 09/15/2022
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Read more Read more link
The Washington Post | 07/27/2022
Longtime HIV Patient is Effectively Cured After Stem Cell Transplant
Read more Read more link
Back to top